Abbott Laboratories (ABT) Change in Accured Expenses (2009)

Abbott Laboratories' (ABT) quarterly Change in Accured Expenses came in at $422.4 million in Q4 2009.

Abbott Laboratories (ABT) Change in Accured Expenses (2009) Analysis & Trends

Abbott Laboratories has disclosed Change in Accured Expenses across 1 years of filings, most recently posting $422.4 million for Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-654.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	703.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-512.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-347.10 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	21.07 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	145.10 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-250.00 Mn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	74.30 Mn
10	Zimmer Biomet Holdings	17.18 Bn	16.77 Bn	1.51 Bn	-183.00 Mn

Download Data

Date	Value
Dec 31, 2009	422.42 Mn
Dec 31, 2009	422.42 Mn